Atlas Trials

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia

Clinical trial NCT02851069 · COMPLETED

Trial details

NCT number
NCT02851069
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Hepatitis C
Start date
2017-02-23
Primary completion
2018-08-30
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.